GH Research (GHRS) Share-based Compensation (2021 - 2025)

GH Research's (GHRS) quarterly Share-based Compensation came in at $2.7 million in Q4 2025, up 249.93% year-on-year from $759000.0 in Q4 2024, and up 13.8% quarter-over-quarter from $2.3 million in Q3 2025.

GH Research (GHRS) Share-based Compensation (2021 - 2025) Analysis & Trends

GH Research's Share-based Compensation history runs 5 years deep, the most recent figure standing at $2.7 million for Q4 2025.

  • On a quarterly basis, Share-based Compensation rose 249.93% year-over-year to $2.7 million in Q4 2025; TTM through Dec 2025 was $8.5 million, a 626.22% increase from a year earlier, with the FY2025 full-year figure at $13.1 million, up 167.72% from the prior year.
  • Share-based Compensation rose to $2.7 million in Q4 2025 per GHRS's latest filing, from $2.3 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $2.7 million in Q4 2025 and bottomed at -$138000.0 in Q2 2024.
  • The 5-year median for Share-based Compensation is $477000.0 (2022), against an average of $778888.9.
  • Across the five-year window, Share-based Compensation tumbled 130.6% in 2024 and surged 1461.59% in 2025, its largest moves.
  • Year by year, Share-based Compensation stood at $235000.0 in 2021, then jumped by 107.66% to $488000.0 in 2022, then soared by 31.56% to $642000.0 in 2023, then advanced by 18.22% to $759000.0 in 2024, then jumped by 249.93% to $2.7 million in 2025.
  • Per Business Quant, the three latest GHRS Share-based Compensation figures stand at $2.7 million (Q4 2025), $2.3 million (Q3 2025), and $1.9 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - 6.39 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 3.20 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 9.26 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 166.40 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 257.40 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - 87.30 Mn
10 GH Research 1.65 Bn 1.65 Bn - 2.66 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 2.66 Mn
Dec 31, 2025 2.66 Mn
Sep 30, 2025 2.33 Mn
Sep 30, 2025 2.33 Mn
Jun 30, 2025 1.88 Mn
Jun 30, 2025 1.88 Mn
Mar 31, 2025 1.64 Mn
Mar 31, 2025 1.64 Mn
Dec 31, 2024 759,000.00
Dec 31, 2024 759,000.00
Sep 30, 2024 273,000.00
Sep 30, 2024 273,000.00
Jun 30, 2024 -138,000.00
Jun 30, 2024 -138,000.00
Mar 31, 2024 277,000.00
Mar 31, 2024 277,000.00
Dec 31, 2023 642,000.00
Dec 31, 2023 642,000.00
Sep 30, 2023 647,000.00
Sep 30, 2023 647,000.00